Mining Clinical Data for Novel PTSD Medications
Despite the prevalence and negative impact of posttraumatic stress disorder (PTSD), there are few medications approved by the United States Food and Drug Administration (FDA) for treatment, and approved medications do not work well enough. We leveraged large-scale electronic health record data to identify existing medications that may be repurposed as PTSD treatments.
Source: Biological Psychiatry - Category: Psychiatry Authors: Brian Shiner, Jenna A. Forehand, Luke Rozema, Martin Kulldorff, Bradley V. Watts, Marina Trefethen, Tammy Jiang, Krista F. Huybrechts, Paula P. Schnurr, Matthew Vincenti, Jiang Gui, Jaimie L. Gradus Tags: Archival Report Source Type: research